Similar outcomes were obtained in the work of Niswander et al. They created anti-FLT3 CAR-T cells and confirmed their high efficiency in eliminating AML cell lines, as well as the eradication of leukemia in MV4-11 and MOLM-14 AML xenograft models [76]. Here, FLT3 is linked to acute myeloid leukemia.